INS and metabolic syndrome: A study demonstrated that Hs treatment in rats with metabolic syndrome caused a reduction in body mass and intra-abdominal fat, as well as in triglycerides, insulin, and leptin levels in relation to the group with metabolic syndrome without treatment (16).